Unmet Medical Need
What Is Fast Track Designation? The FDA’s Most Common Expedited Program Explained
Of all the FDA expedited designations a biotech company can receive, Fast Track Designation is the most commonly granted and, as a result, the least dramatic in terms of immediate stock impact. Yet it is one of the most practically useful regulatory tools available to drug developers, and understanding what it does — and critically,…
What Is Accelerated Approval? The FDA Pathway That Gets Drugs to Patients Faster
Accelerated Approval is one of the FDA’s most powerful and most debated regulatory tools. It allows drugs to be approved and reach patients before the company has generated the full clinical evidence that would normally be required — based on the premise that for serious conditions with unmet needs, earlier access to a promising therapy…
